{"id": "article-26239_0", "title": "Optic Ischemia -- Continuing Education Activity", "content": "Optic ischemia\u00a0is a severe\u00a0condition threatening\u00a0vision integrity\u00a0by causing ischemic damage along the optic nerve's intricate pathway.\u00a0The condition arises from compromised blood flow to the optic nerve, leading to inadequate oxygen and nutrient delivery. This vascular insufficiency can result from various etiologies, including arteriosclerosis, embolic phenomena, vasculitis, or compression of the vascular supply, culminating in ischemic damage to the optic nerve and subsequent vision impairment. Risk factors include hypertension, diabetes mellitus, and smoking.", "contents": "Optic Ischemia -- Continuing Education Activity. Optic ischemia\u00a0is a severe\u00a0condition threatening\u00a0vision integrity\u00a0by causing ischemic damage along the optic nerve's intricate pathway.\u00a0The condition arises from compromised blood flow to the optic nerve, leading to inadequate oxygen and nutrient delivery. This vascular insufficiency can result from various etiologies, including arteriosclerosis, embolic phenomena, vasculitis, or compression of the vascular supply, culminating in ischemic damage to the optic nerve and subsequent vision impairment. Risk factors include hypertension, diabetes mellitus, and smoking."}
{"id": "article-26239_1", "title": "Optic Ischemia -- Continuing Education Activity", "content": "The diagnosis of optic ischemia entails a multifaceted approach combining clinical evaluation, imaging, and ancillary tests to\u00a0determine the underlying cause and severity. Early detection is pivotal for preventing irreversible vision loss and\u00a0deciding\u00a0effective management strategies.\u00a0Treatment of optic ischemia aims to address the underlying cause while optimizing ocular perfusion and preserving vision. Interventions may include managing systemic vascular risk factors, antiplatelet therapy, vasodilators, corticosteroids (in cases of vasculitis), and surgical interventions to improve blood flow.", "contents": "Optic Ischemia -- Continuing Education Activity. The diagnosis of optic ischemia entails a multifaceted approach combining clinical evaluation, imaging, and ancillary tests to\u00a0determine the underlying cause and severity. Early detection is pivotal for preventing irreversible vision loss and\u00a0deciding\u00a0effective management strategies.\u00a0Treatment of optic ischemia aims to address the underlying cause while optimizing ocular perfusion and preserving vision. Interventions may include managing systemic vascular risk factors, antiplatelet therapy, vasodilators, corticosteroids (in cases of vasculitis), and surgical interventions to improve blood flow."}
{"id": "article-26239_2", "title": "Optic Ischemia -- Continuing Education Activity", "content": "This activity for healthcare workers is designed to enhance learners' competence in evaluating and managing optic ischemia. Participants gain a deeper grasp\u00a0of the optic nerve's anatomy, vascular supply, and susceptibility to ischemic insults. Learners also enhance their\u00a0understanding of optic ischemia's pathophysiology, symptomatology, complications, and\u00a0treatment urgency. Participants become prepared to collaborate effectively within an interprofessional team to enhance outcomes for patients with this disorder.", "contents": "Optic Ischemia -- Continuing Education Activity. This activity for healthcare workers is designed to enhance learners' competence in evaluating and managing optic ischemia. Participants gain a deeper grasp\u00a0of the optic nerve's anatomy, vascular supply, and susceptibility to ischemic insults. Learners also enhance their\u00a0understanding of optic ischemia's pathophysiology, symptomatology, complications, and\u00a0treatment urgency. Participants become prepared to collaborate effectively within an interprofessional team to enhance outcomes for patients with this disorder."}
{"id": "article-26239_3", "title": "Optic Ischemia -- Continuing Education Activity", "content": "Objectives: Differentiate the various etiologies of optic ischemia. Create a clinically guided diagnostic strategy for a patient with suspected optic ischemia. Implement comprehensive treatment plans for optic ischemia, utilizing evidence-based interventions to target the underlying etiology, mitigate further ischemic damage, and preserve remaining vision. Apply effective strategies to improve care coordination among interprofessional team members to facilitate positive outcomes for patients with optic ischemia. Access free multiple choice questions on this topic.", "contents": "Optic Ischemia -- Continuing Education Activity. Objectives: Differentiate the various etiologies of optic ischemia. Create a clinically guided diagnostic strategy for a patient with suspected optic ischemia. Implement comprehensive treatment plans for optic ischemia, utilizing evidence-based interventions to target the underlying etiology, mitigate further ischemic damage, and preserve remaining vision. Apply effective strategies to improve care coordination among interprofessional team members to facilitate positive outcomes for patients with optic ischemia. Access free multiple choice questions on this topic."}
{"id": "article-26239_4", "title": "Optic Ischemia -- Introduction -- Optic Ischemia Overview", "content": "Optic ischemia,\u00a0otherwise known as\u00a0ischemic optic neuropathy, encompasses vascular diseases affecting the optic nerve. The condition is categorized into anterior and posterior types.\u00a0Anterior ischemic optic neuropathies often present with optic disc edema, while posterior ones do not.", "contents": "Optic Ischemia -- Introduction -- Optic Ischemia Overview. Optic ischemia,\u00a0otherwise known as\u00a0ischemic optic neuropathy, encompasses vascular diseases affecting the optic nerve. The condition is categorized into anterior and posterior types.\u00a0Anterior ischemic optic neuropathies often present with optic disc edema, while posterior ones do not."}
{"id": "article-26239_5", "title": "Optic Ischemia -- Introduction -- Optic Ischemia Overview", "content": "Nonarteritic acute anterior ischemic optic neuropathy (NAION) is\u00a0the most common form of optic ischemia, typically occurring in individuals with a small, crowded optic nerve.\u00a0However,\u00a0the exact cause of this disorder remains unknown, and curative or preventive treatment is not available. Posterior ischemic optic neuropathy is rare and typically associated with cardiovascular risk factors or perioperative conditions.\u00a0This subset also lacks specific treatment.", "contents": "Optic Ischemia -- Introduction -- Optic Ischemia Overview. Nonarteritic acute anterior ischemic optic neuropathy (NAION) is\u00a0the most common form of optic ischemia, typically occurring in individuals with a small, crowded optic nerve.\u00a0However,\u00a0the exact cause of this disorder remains unknown, and curative or preventive treatment is not available. Posterior ischemic optic neuropathy is rare and typically associated with cardiovascular risk factors or perioperative conditions.\u00a0This subset also lacks specific treatment."}
{"id": "article-26239_6", "title": "Optic Ischemia -- Introduction -- Optic Ischemia Overview", "content": "Urgent evaluation for arteritic causes, notably giant-cell arteritis (GCA), is essential, with immediate intravenous methylprednisolone administration indicated to limit vision loss in the affected eye and prevent involvement of the other eye. [1]", "contents": "Optic Ischemia -- Introduction -- Optic Ischemia Overview. Urgent evaluation for arteritic causes, notably giant-cell arteritis (GCA), is essential, with immediate intravenous methylprednisolone administration indicated to limit vision loss in the affected eye and prevent involvement of the other eye. [1]"}
{"id": "article-26239_7", "title": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy", "content": "The optic nerve spans from the eyeball to the chiasm and\u00a0has 4 segments: intraocular (1 mm), intra-orbital (30 mm), intracanalicular (6-10 mm), and intracranial (10-16 mm). Nerve fibers arise from retinal ganglion cells and converge at the optic disc, commonly known as \"the blind spot,\" before traveling approximately 1 mm within the globe and penetrating the sclera through\u00a0a sieve-like structure called\u00a0\"lamina cribrosa.\" Encased by the optic nerve sheath, the optic nerve also sits amid extraocular muscles and fat tissue.", "contents": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy. The optic nerve spans from the eyeball to the chiasm and\u00a0has 4 segments: intraocular (1 mm), intra-orbital (30 mm), intracanalicular (6-10 mm), and intracranial (10-16 mm). Nerve fibers arise from retinal ganglion cells and converge at the optic disc, commonly known as \"the blind spot,\" before traveling approximately 1 mm within the globe and penetrating the sclera through\u00a0a sieve-like structure called\u00a0\"lamina cribrosa.\" Encased by the optic nerve sheath, the optic nerve also sits amid extraocular muscles and fat tissue."}
{"id": "article-26239_8", "title": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy", "content": "The optic nerve has a diameter of about 3 mm, while the optic nerve sheath measures approximately 1 mm thick. The sheath\u00a0consists\u00a0of\u00a0the pia mater, subarachnoid space, arachnoid mater, and dura mater. This\u00a0covering\u00a0varies in thickness from 0.09 to 0.15 mm for the pia and arachnoid mater, to 0.1\u00a0to 0.29 mm for the subarachnoid space, and 0.3 to 0.5 mm for the dura. The subarachnoid space features a complex structure of trabeculae, septa, and pillars immersed in cerebral spinal fluid, with variations along the nerve's course. [2]", "contents": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy. The optic nerve has a diameter of about 3 mm, while the optic nerve sheath measures approximately 1 mm thick. The sheath\u00a0consists\u00a0of\u00a0the pia mater, subarachnoid space, arachnoid mater, and dura mater. This\u00a0covering\u00a0varies in thickness from 0.09 to 0.15 mm for the pia and arachnoid mater, to 0.1\u00a0to 0.29 mm for the subarachnoid space, and 0.3 to 0.5 mm for the dura. The subarachnoid space features a complex structure of trabeculae, septa, and pillars immersed in cerebral spinal fluid, with variations along the nerve's course. [2]"}
{"id": "article-26239_9", "title": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy", "content": "The optic nerve is divided into anterior and posterior portions\u00a0and\u00a0may be damaged by ischemia anywhere along its path. The optic nerve area between the retina and sclera is supplied by a network of 6 to 12 short posterior ciliary arteries at the back of the globe. These vessels form a circumferential network called the \"circle of Zinn-Haller.\" The optic nerve head is perfused in a centripetal and segmental fashion. Branches from the pial plexus supply the optic nerve's retrolaminar portion. [3]", "contents": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy. The optic nerve is divided into anterior and posterior portions\u00a0and\u00a0may be damaged by ischemia anywhere along its path. The optic nerve area between the retina and sclera is supplied by a network of 6 to 12 short posterior ciliary arteries at the back of the globe. These vessels form a circumferential network called the \"circle of Zinn-Haller.\" The optic nerve head is perfused in a centripetal and segmental fashion. Branches from the pial plexus supply the optic nerve's retrolaminar portion. [3]"}
{"id": "article-26239_10", "title": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy", "content": "The anterior part contains\u00a0trabeculae of\u00a05 to 7 \u00b5m\u00a0diameter, while the midsection exhibits septa and pillars dividing the space into communicating chambers, with pillars ranging from 10\u00a0to 30 \u00b5m in diameter.\u00a0Both pillars and trabeculae are present in the posterior part, where the sheath traverses the optic canal. The right and left optic nerves cross each other\u00a0within the cranium, forming the optic chiasm and\u00a0connecting with the visual cortex within the occipital lobe. [4]", "contents": "Optic Ischemia -- Introduction -- Optic Nerve Anatomy. The anterior part contains\u00a0trabeculae of\u00a05 to 7 \u00b5m\u00a0diameter, while the midsection exhibits septa and pillars dividing the space into communicating chambers, with pillars ranging from 10\u00a0to 30 \u00b5m in diameter.\u00a0Both pillars and trabeculae are present in the posterior part, where the sheath traverses the optic canal. The right and left optic nerves cross each other\u00a0within the cranium, forming the optic chiasm and\u00a0connecting with the visual cortex within the occipital lobe. [4]"}
{"id": "article-26239_11", "title": "Optic Ischemia -- Etiology", "content": "Anterior ischemic optic neuropathy (AION) is far more common than posterior ischemic optic neuropathy (PION). AION is further divided into arteritic and nonarteritic forms.", "contents": "Optic Ischemia -- Etiology. Anterior ischemic optic neuropathy (AION) is far more common than posterior ischemic optic neuropathy (PION). AION is further divided into arteritic and nonarteritic forms."}
{"id": "article-26239_12", "title": "Optic Ischemia -- Etiology -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "Arteritic\u00a0AION (AAION) occurs in patients older than\u00a070.\u00a0The condition\u00a0arises from inflammatory and thrombotic occlusion of short posterior ciliary arteries.\u00a0AAION is associated with systemic vasculitis, GCA being\u00a0its most common cause. [5]", "contents": "Optic Ischemia -- Etiology -- Arteritic Anterior Ischemic Optic Neuropathy. Arteritic\u00a0AION (AAION) occurs in patients older than\u00a070.\u00a0The condition\u00a0arises from inflammatory and thrombotic occlusion of short posterior ciliary arteries.\u00a0AAION is associated with systemic vasculitis, GCA being\u00a0its most common cause. [5]"}
{"id": "article-26239_13", "title": "Optic Ischemia -- Etiology -- Nonarteritic\u00a0Anterior\u00a0Ischemic\u00a0Optic\u00a0Neuropathy", "content": "The cause of nonarteritic\u00a0AION (NAION) is uncertain.\u00a0However, anatomical structure variation,\u00a0ie, structural crowding of the optic disc, is a major\u00a0contributing factor to this condition's development. This\u00a0optic disc condition is commonly called\u00a0a \"disc at risk.\" The prevailing theory is that autoregulation in the presence of any stress factor leads to capillary filling pressure falling below a critical level and damage. The associated risk factors include: Systemic hypertension [6] Diabetes mellitus [7] Hyperlipidemia [8] Hypercoagulable disorders [9] Sleep apnea [10] Nocturnal hypotension [11] Phosphodiesterase inhibitors (sildenafil) [12] Anemia [13] Smoking [14] Migraine Optic nerve head drusen [15]", "contents": "Optic Ischemia -- Etiology -- Nonarteritic\u00a0Anterior\u00a0Ischemic\u00a0Optic\u00a0Neuropathy. The cause of nonarteritic\u00a0AION (NAION) is uncertain.\u00a0However, anatomical structure variation,\u00a0ie, structural crowding of the optic disc, is a major\u00a0contributing factor to this condition's development. This\u00a0optic disc condition is commonly called\u00a0a \"disc at risk.\" The prevailing theory is that autoregulation in the presence of any stress factor leads to capillary filling pressure falling below a critical level and damage. The associated risk factors include: Systemic hypertension [6] Diabetes mellitus [7] Hyperlipidemia [8] Hypercoagulable disorders [9] Sleep apnea [10] Nocturnal hypotension [11] Phosphodiesterase inhibitors (sildenafil) [12] Anemia [13] Smoking [14] Migraine Optic nerve head drusen [15]"}
{"id": "article-26239_14", "title": "Optic Ischemia -- Etiology -- Posterior\u00a0Ischemic\u00a0Optic\u00a0Neuropathy", "content": "PION is notably less prevalent than AION, mainly occurring under\u00a03 circumstances. First, PION\u00a0may arise in perioperative settings, particularly during spinal, cardiac, head, and neck surgeries.\u00a0Factors such as\u00a0significant blood loss, prolonged anesthesia, and hypotension during this period can compromise the optic nerve's blood supply. This etiology is most common in this group. [16] Second, PION may occur in arteritic cases, with\u00a0GCA being the most common culprit. [17] Third, nonarteritic PION\u00a0may develop from\u00a0conditions\u00a0similar to NAION.", "contents": "Optic Ischemia -- Etiology -- Posterior\u00a0Ischemic\u00a0Optic\u00a0Neuropathy. PION is notably less prevalent than AION, mainly occurring under\u00a03 circumstances. First, PION\u00a0may arise in perioperative settings, particularly during spinal, cardiac, head, and neck surgeries.\u00a0Factors such as\u00a0significant blood loss, prolonged anesthesia, and hypotension during this period can compromise the optic nerve's blood supply. This etiology is most common in this group. [16] Second, PION may occur in arteritic cases, with\u00a0GCA being the most common culprit. [17] Third, nonarteritic PION\u00a0may develop from\u00a0conditions\u00a0similar to NAION."}
{"id": "article-26239_15", "title": "Optic Ischemia -- Epidemiology", "content": "NAION\u00a0comprises\u00a0most AION cases (nearly 85%), with an estimated 6000 new cases annually in the United States.\u00a0NAION more commonly affects men and white individuals. The condition's annual incidence rate is 10.3 per 1000,000 people, with the median age being 72 at diagnosis. [18] AAION is much less common, with an annual incidence of 0.36 cases per 100,000 people. [19]", "contents": "Optic Ischemia -- Epidemiology. NAION\u00a0comprises\u00a0most AION cases (nearly 85%), with an estimated 6000 new cases annually in the United States.\u00a0NAION more commonly affects men and white individuals. The condition's annual incidence rate is 10.3 per 1000,000 people, with the median age being 72 at diagnosis. [18] AAION is much less common, with an annual incidence of 0.36 cases per 100,000 people. [19]"}
{"id": "article-26239_16", "title": "Optic Ischemia -- History and Physical", "content": "Individuals with optic ischemia typically present with sudden, painless loss of vision. Other signs and symptoms depend on the type involved, as explained below. Patients should be asked about the\u00a0onset and duration of visual symptoms. Associated symptoms like headache, jaw pain, or scalp tenderness may indicate underlying conditions like GCA.\u00a0Other information that must be elicited includes\u00a0systemic vascular risk factors, current medications, surgical history (especially head, neck, or cardiovascular procedures), and family history of ocular or vascular diseases.", "contents": "Optic Ischemia -- History and Physical. Individuals with optic ischemia typically present with sudden, painless loss of vision. Other signs and symptoms depend on the type involved, as explained below. Patients should be asked about the\u00a0onset and duration of visual symptoms. Associated symptoms like headache, jaw pain, or scalp tenderness may indicate underlying conditions like GCA.\u00a0Other information that must be elicited includes\u00a0systemic vascular risk factors, current medications, surgical history (especially head, neck, or cardiovascular procedures), and family history of ocular or vascular diseases."}
{"id": "article-26239_17", "title": "Optic Ischemia -- History and Physical", "content": "The physical examination findings vary depending on the nerve part and pathophysiologic mechanism\u00a0involved. The patient's visual acuity must be assessed using standard charts. A formal visual field test and funduscopy are recommended. Pupillary responses, intraocular pressure, and extraocular movements must be evaluated.\u00a0A\u00a0comprehensive systemic examination should be performed, including vital signs, cardiovascular evaluation, and signs of systemic vasculitis, which may also\u00a0guide\u00a0diagnosis and treatment.", "contents": "Optic Ischemia -- History and Physical. The physical examination findings vary depending on the nerve part and pathophysiologic mechanism\u00a0involved. The patient's visual acuity must be assessed using standard charts. A formal visual field test and funduscopy are recommended. Pupillary responses, intraocular pressure, and extraocular movements must be evaluated.\u00a0A\u00a0comprehensive systemic examination should be performed, including vital signs, cardiovascular evaluation, and signs of systemic vasculitis, which may also\u00a0guide\u00a0diagnosis and treatment."}
{"id": "article-26239_18", "title": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "AAION usually occurs in older patients\u00a0(mean age of 70 years).\u00a0Most cases are linked to vasculitis, with GCA being the most common. Vision loss is severe, at less than 20/200 in 70% of cases, while 20% of patients\u00a0have no light perception. [20] [21]", "contents": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy. AAION usually occurs in older patients\u00a0(mean age of 70 years).\u00a0Most cases are linked to vasculitis, with GCA being the most common. Vision loss is severe, at less than 20/200 in 70% of cases, while 20% of patients\u00a0have no light perception. [20] [21]"}
{"id": "article-26239_19", "title": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "Inquiring about GCA symptoms is crucial due to the high risk of vision loss in the fellow eye without prompt treatment, often occurring rapidly. GCA is also associated with other potentially life-threatening complications, such as stroke, aortic dissection, and myocardial infarction, which are preventable with timely intervention.", "contents": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy. Inquiring about GCA symptoms is crucial due to the high risk of vision loss in the fellow eye without prompt treatment, often occurring rapidly. GCA is also associated with other potentially life-threatening complications, such as stroke, aortic dissection, and myocardial infarction, which are preventable with timely intervention."}
{"id": "article-26239_20", "title": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "Systemic GCA symptoms\u00a0include temporal headache, scalp tenderness, and jaw claudication\u00a0due to masseter muscle ischemia. Patients may also experience nonspecific manifestations such as weight loss, fever, night sweats, malaise, and depression. Polymyalgia rheumatica\u00a0commonly coexists with GCA. The condition is\u00a0characterized by pain and stiffness in proximal muscle groups like shoulders and thighs.", "contents": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy. Systemic GCA symptoms\u00a0include temporal headache, scalp tenderness, and jaw claudication\u00a0due to masseter muscle ischemia. Patients may also experience nonspecific manifestations such as weight loss, fever, night sweats, malaise, and depression. Polymyalgia rheumatica\u00a0commonly coexists with GCA. The condition is\u00a0characterized by pain and stiffness in proximal muscle groups like shoulders and thighs."}
{"id": "article-26239_21", "title": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "The 2022 American College of Rheumatology Criteria for Giant Cell Arteritis\u00a0has classification guidelines for diagnosing GCA, particularly useful when confirming medium or large vessel vasculitis.\u00a0The diagnosis requires a\u00a0total\u00a0score of 6 or more points based on the criteria and their respective point values.\u00a0Table 1 shows\u00a0the criteria and point values (see Table . 2022 American College of Rheumatology Criteria for Giant Cell Arteritis). [22]", "contents": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy. The 2022 American College of Rheumatology Criteria for Giant Cell Arteritis\u00a0has classification guidelines for diagnosing GCA, particularly useful when confirming medium or large vessel vasculitis.\u00a0The diagnosis requires a\u00a0total\u00a0score of 6 or more points based on the criteria and their respective point values.\u00a0Table 1 shows\u00a0the criteria and point values (see Table . 2022 American College of Rheumatology Criteria for Giant Cell Arteritis). [22]"}
{"id": "article-26239_22", "title": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "Pupil reaction is sluggish on examination, with a relative afferent pupillary deficit\u00a0unless\u00a0both eyes are\u00a0examined\u00a0simultaneously.\u00a0The fundus examination\u00a0may show\u00a0chalky white optic disc edema, indicative of swelling at the optic nerve head.\u00a0Cotton wool spots are\u00a0areas of\u00a0retinal ischemia resulting from impaired blood flow to the nerve fiber layer. These spots may appear distant from the optic disc edema but are important signs of ischemia within the retinal layers (see Image . Giant Cell Arteritis Funduscopic Findings).", "contents": "Optic Ischemia -- History and Physical -- Arteritic Anterior Ischemic Optic Neuropathy. Pupil reaction is sluggish on examination, with a relative afferent pupillary deficit\u00a0unless\u00a0both eyes are\u00a0examined\u00a0simultaneously.\u00a0The fundus examination\u00a0may show\u00a0chalky white optic disc edema, indicative of swelling at the optic nerve head.\u00a0Cotton wool spots are\u00a0areas of\u00a0retinal ischemia resulting from impaired blood flow to the nerve fiber layer. These spots may appear distant from the optic disc edema but are important signs of ischemia within the retinal layers (see Image . Giant Cell Arteritis Funduscopic Findings)."}
{"id": "article-26239_23", "title": "Optic Ischemia -- History and Physical -- Nonarteritic Anterior Ischemic Optic Neuropathy", "content": "NAION\u00a0vision loss\u00a0may\u00a0be acute, subacute, or stepwise and is not usually associated with pain. Vision loss is less severe than in AAION, as\u00a0about half of patients\u00a0have a\u00a020/60 visual acuity examination result or better. [24] [25] Patients usually report vision loss after awakening in the morning, which may progress over weeks to months before the final stabilization of vision.", "contents": "Optic Ischemia -- History and Physical -- Nonarteritic Anterior Ischemic Optic Neuropathy. NAION\u00a0vision loss\u00a0may\u00a0be acute, subacute, or stepwise and is not usually associated with pain. Vision loss is less severe than in AAION, as\u00a0about half of patients\u00a0have a\u00a020/60 visual acuity examination result or better. [24] [25] Patients usually report vision loss after awakening in the morning, which may progress over weeks to months before the final stabilization of vision."}
{"id": "article-26239_24", "title": "Optic Ischemia -- History and Physical -- Nonarteritic Anterior Ischemic Optic Neuropathy", "content": "Fundus examination in the acute stage\u00a0often exhibits\u00a0diffuse or segmental optic disc edema on the affected side, predominantly in the superior or inferior regions. This finding is accompanied by heightened perfusion, characterized by hyperemia. Small hemorrhages may also be observable near the optic nerve head. The fellow eye\u00a0usually shows a small or absent cup,\u00a0with a cup-to-disc ratio of 0.2 or less, indicative of a disc at risk.", "contents": "Optic Ischemia -- History and Physical -- Nonarteritic Anterior Ischemic Optic Neuropathy. Fundus examination in the acute stage\u00a0often exhibits\u00a0diffuse or segmental optic disc edema on the affected side, predominantly in the superior or inferior regions. This finding is accompanied by heightened perfusion, characterized by hyperemia. Small hemorrhages may also be observable near the optic nerve head. The fellow eye\u00a0usually shows a small or absent cup,\u00a0with a cup-to-disc ratio of 0.2 or less, indicative of a disc at risk."}
{"id": "article-26239_25", "title": "Optic Ischemia -- History and Physical -- Nonarteritic Anterior Ischemic Optic Neuropathy", "content": "Optic edema gradually resolves, leading to decreased nerve fiber\u00a0crowding\u00a0and subsequent optic cup enlargement as atrophy develops. The second eye becomes involved gradually, resembling pseudo-Foster-Kennedy syndrome, where one eye shows atrophy while the other exhibits hyperemia and swelling. [26] True Foster-Kennedy syndrome\u00a0exhibits\u00a0optic disc atrophy in one eye due to optic nerve compression by an intracranial mass,\u00a0while\u00a0the contralateral eye presents with optic disc edema due to elevated intracranial pressure.", "contents": "Optic Ischemia -- History and Physical -- Nonarteritic Anterior Ischemic Optic Neuropathy. Optic edema gradually resolves, leading to decreased nerve fiber\u00a0crowding\u00a0and subsequent optic cup enlargement as atrophy develops. The second eye becomes involved gradually, resembling pseudo-Foster-Kennedy syndrome, where one eye shows atrophy while the other exhibits hyperemia and swelling. [26] True Foster-Kennedy syndrome\u00a0exhibits\u00a0optic disc atrophy in one eye due to optic nerve compression by an intracranial mass,\u00a0while\u00a0the contralateral eye presents with optic disc edema due to elevated intracranial pressure."}
{"id": "article-26239_26", "title": "Optic Ischemia -- History and Physical -- Posterior\u00a0Ischemic Optic Neuropathy", "content": "PION's vision loss may be unilateral or bilateral.\u00a0Optic disc edema is absent in the acute stages, though\u00a0optic atrophy typically\u00a0occurs\u00a0after a few months.\u00a0PION\u00a0is a rare disease and is mainly considered a diagnosis of exclusion.\u00a0The condition\u00a0is associated with\u00a0radical neck dissection\u00a0or\u00a0spine surgery.", "contents": "Optic Ischemia -- History and Physical -- Posterior\u00a0Ischemic Optic Neuropathy. PION's vision loss may be unilateral or bilateral.\u00a0Optic disc edema is absent in the acute stages, though\u00a0optic atrophy typically\u00a0occurs\u00a0after a few months.\u00a0PION\u00a0is a rare disease and is mainly considered a diagnosis of exclusion.\u00a0The condition\u00a0is associated with\u00a0radical neck dissection\u00a0or\u00a0spine surgery."}
{"id": "article-26239_27", "title": "Optic Ischemia -- Evaluation", "content": "GCA should always be ruled out in individuals with AAION. Elevated ESR and CRP are sensitive but not specific to GCA. Temporal artery biopsy\u00a0may help rule out GCA. A minimum arterial specimen length of 2 cm is required. [27] Biopsy findings often reveal granulomatous inflammation involving the internal elastic lamina (see Image .\u00a0Superficial Temporal Artery Histopathology). However, biopsies\u00a0may occasionally yield false-negative results, prompting the use of noninvasive techniques such as magnetic resonance imaging (MRI)\u00a0and Doppler ultrasound (see Image . Giant Cell Arteritis on Magnetic Resonance Imaging.). [28] [29] [30]", "contents": "Optic Ischemia -- Evaluation. GCA should always be ruled out in individuals with AAION. Elevated ESR and CRP are sensitive but not specific to GCA. Temporal artery biopsy\u00a0may help rule out GCA. A minimum arterial specimen length of 2 cm is required. [27] Biopsy findings often reveal granulomatous inflammation involving the internal elastic lamina (see Image .\u00a0Superficial Temporal Artery Histopathology). However, biopsies\u00a0may occasionally yield false-negative results, prompting the use of noninvasive techniques such as magnetic resonance imaging (MRI)\u00a0and Doppler ultrasound (see Image . Giant Cell Arteritis on Magnetic Resonance Imaging.). [28] [29] [30]"}
{"id": "article-26239_28", "title": "Optic Ischemia -- Evaluation", "content": "Vascular risk factors must be assessed, including blood pressure, lipid profile, blood glucose, and hemoglobin A1c levels, as patients may be unaware of them. Patients must be asked sleep apnea screening questions.\u00a0The patient's\u00a0medications must be reviewed,\u00a0assessing for phosphodiesterase type 5 inhibitor intake to rule out nocturnal hypotension. Testing for hyperhomocysteinemia is recommended in individuals younger than 50.", "contents": "Optic Ischemia -- Evaluation. Vascular risk factors must be assessed, including blood pressure, lipid profile, blood glucose, and hemoglobin A1c levels, as patients may be unaware of them. Patients must be asked sleep apnea screening questions.\u00a0The patient's\u00a0medications must be reviewed,\u00a0assessing for phosphodiesterase type 5 inhibitor intake to rule out nocturnal hypotension. Testing for hyperhomocysteinemia is recommended in individuals younger than 50."}
{"id": "article-26239_29", "title": "Optic Ischemia -- Evaluation", "content": "Normal choroidal filling on\u00a0fluorescein angiography occurs\u00a03 to 5 seconds\u00a0faster than the retinal arteries. However, AAION\u00a0exhibits\u00a0delayed choroidal filling. Visual fields are often abnormal on confrontation tests like finger counting and consistently show abnormalities with automated perimetry, frequently presenting as an altitudinal defect, commonly inferiorly.", "contents": "Optic Ischemia -- Evaluation. Normal choroidal filling on\u00a0fluorescein angiography occurs\u00a03 to 5 seconds\u00a0faster than the retinal arteries. However, AAION\u00a0exhibits\u00a0delayed choroidal filling. Visual fields are often abnormal on confrontation tests like finger counting and consistently show abnormalities with automated perimetry, frequently presenting as an altitudinal defect, commonly inferiorly."}
{"id": "article-26239_30", "title": "Optic Ischemia -- Treatment / Management -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "High-dose corticosteroids should be started immediately in cases of high suspicion after drawing blood samples for CBC, ESR, and CRP. The lab results should not delay corticosteroid administration. Immediate treatment prevents vision loss in\u00a0the fellow\u00a0eye, with second eye involvement likely within days to weeks of therapeutic delay. Temporal artery biopsy\u00a0may be postponed for 7 to 10 days if nearby facilities are unavailable.\u00a0Temporal artery pathological changes require weeks to months to alter.", "contents": "Optic Ischemia -- Treatment / Management -- Arteritic Anterior Ischemic Optic Neuropathy. High-dose corticosteroids should be started immediately in cases of high suspicion after drawing blood samples for CBC, ESR, and CRP. The lab results should not delay corticosteroid administration. Immediate treatment prevents vision loss in\u00a0the fellow\u00a0eye, with second eye involvement likely within days to weeks of therapeutic delay. Temporal artery biopsy\u00a0may be postponed for 7 to 10 days if nearby facilities are unavailable.\u00a0Temporal artery pathological changes require weeks to months to alter."}
{"id": "article-26239_31", "title": "Optic Ischemia -- Treatment / Management -- Arteritic Anterior Ischemic Optic Neuropathy", "content": "High-dose intravenous methylprednisolone 1 g/day for 3 to 5 days is preferred. Studies indicate varying durations.\u00a0A 3-day course of high-dose intravenous steroids shows potential benefits for visual recovery in the affected eye and prevention of disease in the fellow eye. [31] [32] The consensus approach involves initiating moderate-to-high dose oral prednisone (1 mg/kg/day) following intravenous therapy, with a gradual taper over 3 to 12 months based on response. ESR and CRP levels should be closely monitored throughout the course.", "contents": "Optic Ischemia -- Treatment / Management -- Arteritic Anterior Ischemic Optic Neuropathy. High-dose intravenous methylprednisolone 1 g/day for 3 to 5 days is preferred. Studies indicate varying durations.\u00a0A 3-day course of high-dose intravenous steroids shows potential benefits for visual recovery in the affected eye and prevention of disease in the fellow eye. [31] [32] The consensus approach involves initiating moderate-to-high dose oral prednisone (1 mg/kg/day) following intravenous therapy, with a gradual taper over 3 to 12 months based on response. ESR and CRP levels should be closely monitored throughout the course."}
{"id": "article-26239_32", "title": "Optic Ischemia -- Treatment / Management -- Nonarteritic Anterior Ischemic Optic Neuropathy", "content": "Therapeutic efficacy for NAION remains debated, with corticosteroids, optic nerve sheath fenestration surgery, and levodopa showing partial effectiveness. [33] [34] [35] Ongoing research explores stem cell therapy, demonstrating promising results. [36] Priority lies in preventing vision loss in the fellow eye. Effective secondary prevention strategies for NAION include controlling diabetes mellitus, hypertension, hyperlipidemia, smoking, and obstructive sleep apnea. [37]", "contents": "Optic Ischemia -- Treatment / Management -- Nonarteritic Anterior Ischemic Optic Neuropathy. Therapeutic efficacy for NAION remains debated, with corticosteroids, optic nerve sheath fenestration surgery, and levodopa showing partial effectiveness. [33] [34] [35] Ongoing research explores stem cell therapy, demonstrating promising results. [36] Priority lies in preventing vision loss in the fellow eye. Effective secondary prevention strategies for NAION include controlling diabetes mellitus, hypertension, hyperlipidemia, smoking, and obstructive sleep apnea. [37]"}
{"id": "article-26239_33", "title": "Optic Ischemia -- Differential Diagnosis", "content": "Optic ischemia, especially NAION, can mimic optic neuritis, as\u00a0it features\u00a0sudden vision loss, relative afferent pupillary\u00a0defect, and optic disc swelling with associated hyperemia.\u00a0Meanwhile,\u00a0optic neuritis' clinical characteristics include the following: Patient\u00a0age\u00a040 years old and younger Painful eye movements Central visual field loss No delayed disc filling on fluorescein angiography Contrast-enhanced MRI may help differentiate these 2 conditions. The affected optic nerve appears normal in NAION, but gadolinium contrast enhances the optic nerve in optic neuritis. [38]", "contents": "Optic Ischemia -- Differential Diagnosis. Optic ischemia, especially NAION, can mimic optic neuritis, as\u00a0it features\u00a0sudden vision loss, relative afferent pupillary\u00a0defect, and optic disc swelling with associated hyperemia.\u00a0Meanwhile,\u00a0optic neuritis' clinical characteristics include the following: Patient\u00a0age\u00a040 years old and younger Painful eye movements Central visual field loss No delayed disc filling on fluorescein angiography Contrast-enhanced MRI may help differentiate these 2 conditions. The affected optic nerve appears normal in NAION, but gadolinium contrast enhances the optic nerve in optic neuritis. [38]"}
{"id": "article-26239_34", "title": "Optic Ischemia -- Differential Diagnosis", "content": "Optic nerve compression can mimic\u00a0AION. Compression can occur from optic nerve tumors, orbital inflammatory disease, or an ophthalmic artery aneurysm. Contrast imaging of the optic nerve's full length is appropriate to differentiate other causes from optic nerve ischemia.", "contents": "Optic Ischemia -- Differential Diagnosis. Optic nerve compression can mimic\u00a0AION. Compression can occur from optic nerve tumors, orbital inflammatory disease, or an ophthalmic artery aneurysm. Contrast imaging of the optic nerve's full length is appropriate to differentiate other causes from optic nerve ischemia."}
{"id": "article-26239_35", "title": "Optic Ischemia -- Differential Diagnosis", "content": "Sometimes, optic disc drusen can mimic optic ischemia. The optic disc appears elevated and small in this condition. Disc blurring occurs due to axoplasmic flow stasis in axons. Most patients with this condition\u00a0lack\u00a0visual symptoms, though a few experience transient visual obscurations.", "contents": "Optic Ischemia -- Differential Diagnosis. Sometimes, optic disc drusen can mimic optic ischemia. The optic disc appears elevated and small in this condition. Disc blurring occurs due to axoplasmic flow stasis in axons. Most patients with this condition\u00a0lack\u00a0visual symptoms, though a few experience transient visual obscurations."}
{"id": "article-26239_36", "title": "Optic Ischemia -- Prognosis", "content": "The prognosis is very poor\u00a0for any type of ischemic optic neuropathy,\u00a0with\u00a0visual loss usually becoming permanent.\u00a0A study\u00a0revealed that the mean visual acuity following NAION was 20/200. [18] Another study found that following NAION, visual acuity of 20/40 or better was achieved in 83 out of 184 eyes, but only\u00a08 out of 45 eyes achieved that visual acuity level in AAION. [39]", "contents": "Optic Ischemia -- Prognosis. The prognosis is very poor\u00a0for any type of ischemic optic neuropathy,\u00a0with\u00a0visual loss usually becoming permanent.\u00a0A study\u00a0revealed that the mean visual acuity following NAION was 20/200. [18] Another study found that following NAION, visual acuity of 20/40 or better was achieved in 83 out of 184 eyes, but only\u00a08 out of 45 eyes achieved that visual acuity level in AAION. [39]"}
{"id": "article-26239_37", "title": "Optic Ischemia -- Complications", "content": "Optic atrophy is the most serious and inevitable complication of neglected optic ischemia, developing over a few months after the ischemic event. [18] Optic nerve atrophy results from the death of optic nerve tissue, leading to complete vision loss in the corresponding visual field area, as the visual signal fails to transmit from the retina to the brain.", "contents": "Optic Ischemia -- Complications. Optic atrophy is the most serious and inevitable complication of neglected optic ischemia, developing over a few months after the ischemic event. [18] Optic nerve atrophy results from the death of optic nerve tissue, leading to complete vision loss in the corresponding visual field area, as the visual signal fails to transmit from the retina to the brain."}
{"id": "article-26239_38", "title": "Optic Ischemia -- Deterrence and Patient Education", "content": "Primary prevention of optic ischemia involves managing\u00a0modifiable\u00a0risk factors like hypertension, hyperlipidemia, obstructive sleep apnea, smoking, and\u00a0diabetes mellitus\u00a0through lifestyle modifications and pharmacological interventions. Regularly monitoring systemic vascular health and early detection of conditions predisposing to optic ischemia, such as giant cell arteritis, are essential.\u00a0Educating patients regarding the importance of\u00a0taking preventive measures and seeking timely medical evaluation for risk factor control can significantly reduce the likelihood of developing optic ischemia.", "contents": "Optic Ischemia -- Deterrence and Patient Education. Primary prevention of optic ischemia involves managing\u00a0modifiable\u00a0risk factors like hypertension, hyperlipidemia, obstructive sleep apnea, smoking, and\u00a0diabetes mellitus\u00a0through lifestyle modifications and pharmacological interventions. Regularly monitoring systemic vascular health and early detection of conditions predisposing to optic ischemia, such as giant cell arteritis, are essential.\u00a0Educating patients regarding the importance of\u00a0taking preventive measures and seeking timely medical evaluation for risk factor control can significantly reduce the likelihood of developing optic ischemia."}
{"id": "article-26239_39", "title": "Optic Ischemia -- Deterrence and Patient Education", "content": "Patients with optic ischemia on one eye should be educated about immediate medical consultation if they experience sudden, severe vision loss on the other. The cruciality of maintaining routine health checkups in preventing\u00a0optic ischemia in the second eye\u00a0to control diseases like hypertension, diabetes, and obstructive sleep apnea should also be emphasized.", "contents": "Optic Ischemia -- Deterrence and Patient Education. Patients with optic ischemia on one eye should be educated about immediate medical consultation if they experience sudden, severe vision loss on the other. The cruciality of maintaining routine health checkups in preventing\u00a0optic ischemia in the second eye\u00a0to control diseases like hypertension, diabetes, and obstructive sleep apnea should also be emphasized."}
{"id": "article-26239_40", "title": "Optic Ischemia -- Deterrence and Patient Education", "content": "AAION is highly associated with GCA. Thus,\u00a0individuals at risk should be\u00a0informed of the importance of seeking\u00a0an immediate investigation\u00a0for symptoms of fever, unintended weight loss, scalp tenderness, and jaw claudication.\u00a0Physician referral should be sought for comprehensive care and prevention of long-term complications associated with systemic steroid therapy, considering the extended treatment duration required for AAION.", "contents": "Optic Ischemia -- Deterrence and Patient Education. AAION is highly associated with GCA. Thus,\u00a0individuals at risk should be\u00a0informed of the importance of seeking\u00a0an immediate investigation\u00a0for symptoms of fever, unintended weight loss, scalp tenderness, and jaw claudication.\u00a0Physician referral should be sought for comprehensive care and prevention of long-term complications associated with systemic steroid therapy, considering the extended treatment duration required for AAION."}
{"id": "article-26239_41", "title": "Optic Ischemia -- Pearls and Other Issues", "content": "Optic ischemia presents diagnostic and management challenges.\u00a0AAION often\u00a0manifests with sudden vision loss. PION may\u00a0develop more insidiously, complicating diagnosis. Careful history-taking to identify risk factors like hypertension, diabetes, and smoking history guides diagnostic evaluation.\u00a0Clinical evaluation must\u00a0include visual acuity assessment,\u00a0visual\u00a0field testing, and optic nerve examination.", "contents": "Optic Ischemia -- Pearls and Other Issues. Optic ischemia presents diagnostic and management challenges.\u00a0AAION often\u00a0manifests with sudden vision loss. PION may\u00a0develop more insidiously, complicating diagnosis. Careful history-taking to identify risk factors like hypertension, diabetes, and smoking history guides diagnostic evaluation.\u00a0Clinical evaluation must\u00a0include visual acuity assessment,\u00a0visual\u00a0field testing, and optic nerve examination."}
{"id": "article-26239_42", "title": "Optic Ischemia -- Pearls and Other Issues", "content": "Recognizing the urgency of early intervention to prevent irreversible vision loss is paramount. Differentiating between arteritic and nonarteritic causes is crucial, with\u00a0GCA requiring immediate treatment to avert bilateral vision impairment. Prompt initiation of high-dose corticosteroids without waiting for laboratory results in suspected GCA cases is imperative to prevent irreversible vision loss.\u00a0Imaging tests aid in assessing optic nerve perfusion and structural changes. A biopsy may be performed to rule out GCA but may be postponed in favor of immediate corticosteroid administration.", "contents": "Optic Ischemia -- Pearls and Other Issues. Recognizing the urgency of early intervention to prevent irreversible vision loss is paramount. Differentiating between arteritic and nonarteritic causes is crucial, with\u00a0GCA requiring immediate treatment to avert bilateral vision impairment. Prompt initiation of high-dose corticosteroids without waiting for laboratory results in suspected GCA cases is imperative to prevent irreversible vision loss.\u00a0Imaging tests aid in assessing optic nerve perfusion and structural changes. A biopsy may be performed to rule out GCA but may be postponed in favor of immediate corticosteroid administration."}
{"id": "article-26239_43", "title": "Optic Ischemia -- Pearls and Other Issues", "content": "Long-term management focuses on systemic risk factor control, regularly monitoring inflammatory markers\u00a0and\u00a0vascular health to prevent recurrent ischemic events.\u00a0Collaborative efforts between clinicians, ophthalmologists, and rheumatologists ensure comprehensive care, emphasizing the importance of managing systemic vascular risk factors to mitigate optic ischemia's impact.", "contents": "Optic Ischemia -- Pearls and Other Issues. Long-term management focuses on systemic risk factor control, regularly monitoring inflammatory markers\u00a0and\u00a0vascular health to prevent recurrent ischemic events.\u00a0Collaborative efforts between clinicians, ophthalmologists, and rheumatologists ensure comprehensive care, emphasizing the importance of managing systemic vascular risk factors to mitigate optic ischemia's impact."}
{"id": "article-26239_44", "title": "Optic Ischemia -- Enhancing Healthcare Team Outcomes", "content": "Patients with optic nerve ischemia often present initially to non-eye care providers, such as primary care and emergency physicians or specialists in various medical fields. These clinicians\u00a0must understand the disease's potential complications\u00a0if not immediately treated. Prompt ophthalmology referral is essential for optimal management. An interprofessional team comprising primary care physicians, neurologists, optometrists, ophthalmologists, radiologists, pathologists, and rheumatologists is ideal for comprehensive management. Close follow-up with this team is vital for treating the affected eye and preventing disease progression in the fellow eye. [40]", "contents": "Optic Ischemia -- Enhancing Healthcare Team Outcomes. Patients with optic nerve ischemia often present initially to non-eye care providers, such as primary care and emergency physicians or specialists in various medical fields. These clinicians\u00a0must understand the disease's potential complications\u00a0if not immediately treated. Prompt ophthalmology referral is essential for optimal management. An interprofessional team comprising primary care physicians, neurologists, optometrists, ophthalmologists, radiologists, pathologists, and rheumatologists is ideal for comprehensive management. Close follow-up with this team is vital for treating the affected eye and preventing disease progression in the fellow eye. [40]"}
{"id": "article-26239_45", "title": "Optic Ischemia -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Optic Ischemia -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}